alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 12.1

RATIO OF EARNINGS TO COMBINED FIXED CHARGES AND PREFERRED DIVIDENDS

AND RATIO OF EARNINGS TO FIXED
CHARGES

The following table sets forth our ratio of earnings to combined fixed charges and preferred dividends and our ratio of earnings to fixed
charges for each of the periods indicated:



|                                                                  |  |                         |   |  |          |  |      |  |      |  |     
|----------------------------------------------------------------- |  | ----------------------- | - |  | -------- |  | ---- |  | ---- |  | ----
|                                                                  |  | Year Ended December 31,
|                                                                  |  |                         |   |  |         
|                                                                  |  | 2008 (A)                |   |  | 2007 (B) |  | 2006 |  | 2005 |  | 2004
|Ratio of Earnings toCombined Fixed Charges andPreferred Dividends |  | (8.32                   | ) |  | 0.84     |  | 1.31 |  | 1.46 |  | 1.62
|                                                                  |  |                         |   |  |         
|Ratio of Earnings to Fixed Charges                                |  | (8.68                   | ) |  | 0.86     |  | 1.34 |  | 1.51 |  | 1.69



|    |  |                                                                                                                                                                                                                 
|--- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|(A) |  | The 2008 deficiencies in each ratio are $2.99 billion and $2.98 billion, respectively. The 2008 results included impairment charges. Excluding such charges, the ratios would have approximately
equaled 1 to 1.
|    | 
|(B) |  | The 2007 deficiencies in each ratio are $77.7 million and $65.1 million, respectively. The 2007 results included impairment charges. Excluding such charges, the ratios would have exceeded 1 to
1.             

For purposes of calculating the above ratios, (i) earnings represent Income (loss) from continuing
operations, excluding equity in earnings of unconsolidated subsidiaries, from our consolidated statements of operations, as adjusted for fixed charges and distributions from unconsolidated subsidiaries, and (ii) fixed charges represent
Interest expense from our consolidated statements of operations. The ratios are based solely on historical financial information.

These ratios
are affected by increasing interest rates. As a result of our match funded financing strategy, increasing interest rates are expected to generally result in an increase to interest expense without a material effect on net income, thereby negatively
impacting these ratios.
IN THE UNITED STATES DISTRICT COURT 

FOR THE WESTERN DISTRICT OF TEXAS

WACO DIVISION

WSOU INVESTMENTS, LLC d/b/a 

BRAZOS LICENSING AND 

DEVELOPMENT,

Plaintiff,

v.

MICROSOFT CORPORATION,

Defendant.

§

§

§

§

§

§

§ 

§ CIVIL ACTION NO. 6:20-cv-454-ADA

§ 

§ JURY TRIAL DEMANDED 

§ 

NOTICE OF APPEARANCE 

Please take notice that attorney Ryan S. Loveless of the law firm ETHERIDGE LAW GROUP, PLLC 

appears as counsel of record for Plaintiff WSOU INVESTMENTS, LLC d/b/a BRAZOS LICENSING 

AND DEVELOPMENT. Mr. Loveless hereby requests that all notices required to be given, and all papers 

required to be served in the above-entitled and numbered cause, be copied to and served upon him.

Dated: June 4, 2020 Respectfully submitted,

/s/ Ryan S. Loveless

Ryan S. Loveless

Texas State Bar No. 24036997

ETHERIDGE LAW GROUP, PLLC

2600 E. Southlake Blvd., Suite 120 / 324

Southlake, Texas 76092

Telephone: (817) 470-7249

Facsimile: (817) 887-5950

Ryan@EtheridgeLaw.com

Case 6:20-cv-00454-ADA Document 7 Filed 06/04/20 Page 1 of 2
CERTIFICATE OF SERVICE

I certify that the foregoing document was served upon all counsel of record via the 

Court's CM/ECF electronic filing system in accordance with the Federal Rules of Civil 

Procedure on June 4, 2020. 

/s/ Ryan S. Loveless

Ryan S. Loveless

Case 6:20-cv-00454-ADA Document 7 Filed 06/04/20 Page 2 of 2
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Health Care Financing Administration 

          - 42 CFR Parts 412, 413 and 489
          - [HCFA-1005-CN2] 
          - RIN 0938-AI56 

# AGENCY:

Health Care Financing Administration (HCFA), HHS. 

# ACTION:

Correction. 

# SUMMARY:

                        This document corrects several typographical errors that appeared in the notice of delay of effective date for the final rule with comment period published in the                         **Federal Register**                         on June 30, 2000, entitled “Medicare Program; Prospective Payment System for Hospital Outpatient Services; Delay of Effective Date.”                     

# EFFECTIVE DATE:

 August 1, 2000. 

# FOR FURTHER INFORMATION CONTACT:

Janet Wellham, (410) 786-4510. 

# SUPPLEMENTARY INFORMATION:

## Background 

                    In FR Doc. 00-16586 of June 30, 2000 (65 FR 40535), there were several typographical errors. The provisions in this correction notice are effective as if they had been included in the document published in the                     **Federal Register**                     on June 30, 2000.                 

## Correction of Errors 

In FR Doc. 00-16586 on June 30, 2000, make the following corrections: 

                    1. On page 40535, column three, in the                     **DATES**                     section, “§ 412.24” is corrected to read “§ 413.24”, and § 489.24(h) is corrected to read “§ 489.24.”                 

2. On page 40537, column one, the third full paragraph, line two, “§ 412.24” is corrected to read “§ 413.24”, and “§ 489.24(h)” is corrected to read “§ 489.24.”

(Catalog of Federal Domestic Assistance Program No. 93.774, Medicare—Supplementary Medical Insurance Program)

Dated: September 21, 2000.

Brian P. Burns, 

Deputy Assistant Secretary for Information Resources Management. 

[FR Doc. 00-25498 Filed 10-5-00; 8:45 am] 

BILLING CODE 4120-01-P
No. 72-1082.

#### Benners, Executrix *v.*City of University Park.

Appeal from Sup. Ct. Tex. dismissed for want of substantial federal question.
I 

112TH CONGRESS 

2D SESSION H. R. 5439 

To suspend temporarily the rate of duty on Dimethomorph. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 7, 2012 

Mr. LUETKEMEYER introduced the following bill; which was referred to the 

Committee on Ways and Means 

A BILL 

To suspend temporarily the rate of duty on Dimethomorph. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. DIMETHOMORPH. 

4 (a) IN GENERAL.—Subchapter II of chapter 99 of 

5 the Harmonized Tariff Schedule of the United States is 

6 amended by inserting in numerical sequence the following 

7 new heading: 

‘‘ 9902.01.00 4-[3-(4-chlorophenyl)-3- 

(3,4-dimethoxyphenyl)-1- 

oxo-2-propenyl]morpholine 

(Dimethomorph) (CAS No. 

110488–70–5) (provided 

for in subheading 

2934.99.12) ....................... Free No change No change On or before 

12/31/2015 ’’. 


tjames on DSK6SPTVN1PROD with BILLS
2 

•HR 5439 IH

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) applies to articles entered, or withdrawn 

3 from warehouse for consumption, on or after the 15th day 

4 after the date of the enactment of this Act. 

Æ 


tjames on DSK6SPTVN1PROD with BILLS
X

n

X

-

C

y

H(2y+1)

C

y

H(2y+1) -CyH(2y+1)
IN THE UNITED STATES DISTRICT COURT

FOR THE WESTERN DISTRICT OF TEXAS 

WACO DIVISION

WSOU INVESTMENTS, LLC D/B/A 

BRAZOS LICENSING AND 

DEVELOPMENT,

Plaintiff,

v. 

MICROSOFT CORPORATION,

Defendant.

§

§

§

§

§

§

§

§

§

§

§

§

§

CIVIL ACTION 6:20-cv-00454-ADA

CIVIL ACTION 6:20-cv-00455-ADA

CIVIL ACTION 6:20-cv-00456-ADA

CIVIL ACTION 6:20-cv-00457-ADA

CIVIL ACTION 6:20-cv-00458-ADA

CIVIL ACTION 6:20-cv-00459-ADA

CIVIL ACTION 6:20-cv-00460-ADA

CIVIL ACTION 6:20-cv-00461-ADA

CIVIL ACTION 6:20-cv-00462-ADA

CIVIL ACTION 6:20-cv-00463-ADA

CIVIL ACTION 6:20-cv-00464-ADA

CIVIL ACTION 6:20-cv-00465-ADA

WSOU’S NOTICE OF COMPLIANCE REGARDING EXCHANGE OF REVISED LIST 

OF TERMS AND CONSTRUCTIONS

TO THE HONORABLE COURT:

Pursuant to the Court’s Version 3.2 of the Court’s Order Governing proceedings entered 

November 5, 2020, and in accordance with the Court’s Scheduling Order, Plaintiff hereby notifies 

the Court Plaintiff has served its revised list of terms and constructions on Defendant Microsoft 

Corporation via electronic mail on December 18, 2020. 

Case 6:20-cv-00454-ADA Document 47 Filed 12/18/20 Page 1 of 2
Date: December 18, 2020 Respectfully submitted,

By: /s/ Mark D. Siegmund_____ 

Mark D. Siegmund

State Bar No. 24117055

mark@waltfairpllc.com

Law Firm of Walt, Fair PLLC.

1508 North Valley Mills Drive 

Waco, Texas 76710

Telephone: (254) 772-6400

Facsimile: (254) 772-6432

Counsel for Plaintiff WSOU Investments, LLC

CERTIFICATE OF SERVICE

A true and correct copy of the foregoing instrument was served or delivered 

electronically via U.S. District Court [LIVE]- Document Filing System, to all counsel of record, 

on this the 18th day of December 2020.

/s/ Mark D. Siegmund

Mark D. Siegmund

Case 6:20-cv-00454-ADA Document 47 Filed 12/18/20 Page 2 of 2
IN THE UNITED STATES DISTRICT COURT 

FOR THE WESTERN DISTRICT OF TEXAS 

WACO DIVISION 

WSOU INVESTMENTS LLC D/B/A 

BRAZOS LICENSING AND 

DEVELOPMENT,

 Plaintiff,

v. 

ZTE CORPORATION, ZTE (USA) INC. 

AND ZTE (TX), INC.,

 Defendants.

§

§

§

§

§

§

§

§

§

§

§

§

§

C.A. NO. 6:20-cv-00487-ADA

C.A. NO. 6:20-cv-00488-ADA

C.A. NO. 6:20-cv-00489-ADA

C.A. NO. 6:20-cv-00490-ADA

C.A. NO. 6:20-cv-00491-ADA

C.A. NO. 6:20-cv-00492-ADA

C.A. NO. 6:20-cv-00493-ADA

C.A. NO. 6:20-cv-00494-ADA

C.A. NO. 6:20-cv-00495-ADA

C.A. NO. 6:20-cv-00496-ADA

C.A. NO. 6:20-cv-00497-ADA

DEFENDANTS’ NOTICE OF COMPLIANCE REGARDING EXCHANGE OF SECOND 

NARROWED CLAIM TERMS FOR CONSTRUCTION

TO THE HONORABLE COURT:

Pursuant to the Court’s First Amended Scheduling Order, Dkt. 45,1 and the Court’s 

February 26, 2021 e-mail order,2 Defendants hereby notify the Court that Defendants served their 

second narrowed claim terms for claim construction on Plaintiff WSOU Investments, LLC d/b/a 

Brazos Licensing and Development via electronic mail on March 1, 2021.

Defendants reserve the remaining identified terms and maintain that they are indefinite, 

lack support, and/or are invalid under 35 U.S.C. §§ 112(a), (b), and (f).

1 There are 11 pending cases. Citations throughout refer to new WDTX Case Nos. -00487 through -00497, and 

specific citations reference to the docket for WDTX Case No. -00487. 2 The e-mail order via e-mail exchanges between the parties and the Court are attached as Ex. 1, and the parties’ 

associated charts referenced in the e-mail exchanges are attached as Ex. 2.

Case 6:20-cv-00487-ADA Document 60 Filed 03/02/21 Page 1 of 2
2

DATED: March 2, 2021 Respectfully submitted,

/s/Lionel M. Lavenue 

Lionel M. Lavenue 

Virginia Bar No. 49,005

lionel.lavenue@finnegan.com 

FINNEGAN, HENDERSON, FARABOW, 

GARRETT & DUNNER, LLP

1875 Explorer Street, Suite 800

Reston, VA 20190

Phone: (571) 203-2700

Fax: (202) 408-4400

Attorney for Defendants

CERTIFICATE OF SERVICE

The undersigned hereby certifies that all counsel of record who are deemed to have 

consented to electronic service are being served with a copy of this document via the Court’s 

CM/ECF system on March 2, 2021.

/s/Lionel M. Lavenue 

 Lionel M. Lavenue

Case 6:20-cv-00487-ADA Document 60 Filed 03/02/21 Page 2 of 2
Jackson-Madison County 

Airport Authority 

.;(\/jj?f^^ll^lPiSl|^i^sil? 

November 15, 2011 

Dennis DeVany, Chief 

Essential Air Service Division 

Department of Transportation 

Wasiiington, DC 20590 

RE: DOT-OST-2000-7857 

Dear Mr. DeVany: 

The Jacl<son Madison County Airport Authority appreciates the opportunity to submit comments 

regarding Essential Air Service for Jackson Tennessee. We ask that Seaport Airlines be chosen as the 

carrier for Jackson Tennessee. 

Seaport proposed 3 options for service in Jackson. The Airport Authority feels that option #2 gives 

Jackson more opportunity to lower the passenger cap by allowing two hub choices for travelers. The 

proposal provides for 18 flights per week with 6 round trips to Memphis and 12 round trips to Nashville. 

The option to fly to Memphis allows traveler's access to Delta Airlines and the option to Nashville 

provides access to Southwest Airlines. 

The Authority is aware that the agreement for service will be for only one year and the ability to 

increase traffic will be critical to retaining service. 

Thanks for considering our comments. 

five Smith 

Jackson-Madison County Airport Authority 

308 Grady Montgomery Drive • Jackson, Tennessee 38301 • Phone: 731-423-0995 • Fax: 731-423-0997
EXHIBIT 32.2

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350)

I, John S. Buchanan, Chief Executive Officer of Accredited Home Lenders Holding Co. (the Registrant), do hereby certify in accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that, based on my knowledge:

(1) the Annual Report on Form 10-K of the Registrant, to which this certification is
attached as an exhibit (the Report), fully complies with the requirements of section 13(a) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
of the Registrant.

Date: March 15, 2006



By:

/s/    JOHN S. BUCHANANJohn S. Buchanan Chief Financial Officer


A signed original of this written statement required by Section 906 has been provided
to Accredited Home Lenders Holding Co. and will be retained by Accredited Home Lenders Holding Co. and furnished to the Securities and Exchange Commission or its staff upon request.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SECTION CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE STANDARD
REGISTER COMPANY FINANCIAL STATEMENTS FOR THE NINE MONTHS ENDED OCTOBER 3, 1999,
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK> 0000093456
<NAME> STANDARD REGISTER COMPANY
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                           JAN-2-2000
<PERIOD-START>                              JAN-4-1999
<PERIOD-END>                                OCT-3-1999
<CASH>                                          63,169
<SECURITIES>                                       480
<RECEIVABLES>                                  271,416
<ALLOWANCES>                                    13,184
<INVENTORY>                                    135,724
<CURRENT-ASSETS>                               488,316
<PP&E>                                         506,661
<DEPRECIATION>                                 172,036
<TOTAL-ASSETS>                                 971,931
<CURRENT-LIABILITIES>                          122,132
<BONDS>                                        203,520
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        29,179
<OTHER-SE>                                     523,642
<TOTAL-LIABILITY-AND-EQUITY>                   971,931
<SALES>                                        987,309
<TOTAL-REVENUES>                               988,523
<CGS>                                          606,029
<TOTAL-COSTS>                                  909,208
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                 4,455
<INTEREST-EXPENSE>                              10,419
<INCOME-PRETAX>                                 68,896
<INCOME-TAX>                                    25,474
<INCOME-CONTINUING>                             43,422
<DISCONTINUED>                                  14,366
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    57,788
<EPS-BASIC>                                       2.05
<EPS-DILUTED>                                     2.03


</TABLE>
EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. 1350,

AS ADOPTED PURSUANT TO

SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

In connection with this Quarterly Report of The Colonial BancGroup, Inc. (the Company)
on Form 10-Q for the period ended September 30, 2007, as filed with the Securities and Exchange Commission on the date hereof (the Report) and to which this certification is furnished as an exhibit, I, Robert E. Lowder, the principal
executive officer of the Company, certify pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



|(1) | The Report fully complies with the requirements of section 13(a) of the Securities Exchange Act of 1934; and
|--- | ------------------------------------------------------------------------------------------------------------



|(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|--- | ----------------------------------------------------------------------------------------------------------------------------------------------------

Date: November 8, 2007



/s/    ROBERT E.
LOWDERRobert E. LowderChief Executive Officer


A signed original of this written statement required by Section 906 has been provided to The
Colonial BancGroup, Inc. and will be retained by The Colonial BancGroup, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
I 

112TH CONGRESS 

2D SESSION H. R. 5569 

To extend the temporary suspension of duty on N-ethyl-N-(3- 

sulfobenzyl)aniline (3- [(ethylphenylamino)methyl]-benzenesulfonic acid). 

IN THE HOUSE OF REPRESENTATIVES 

MAY 8, 2012 

Mr. CLAY introduced the following bill; which was referred to the Committee 

on Ways and Means 

A BILL 

To extend the temporary suspension of duty on N-ethylN-(3-sulfobenzyl)aniline (3- [(ethylphenylamino)methyl]- 

benzenesulfonic acid). 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. N-ETHYL-N-(3-SULFOBENZYL)ANILINE (3- 

4 [(ETHYLPHENYLAMINO)METHYL]- 

5 BENZENESULFONIC ACID). 

6 (a) IN GENERAL.—Heading 9902.01.68 of the Har7 monized Tariff Schedule of the United States (relating to 

8 N-ethyl-N-(3-sulfobenzyl)aniline (3- 

9 [(ethylphenylamino)methyl]-benzenesulfonic acid)) is 


tjames on DSK6SPTVN1PROD with BILLS
2 

•HR 5569 IH

1 amended by striking the date in the effective period col2 umn and inserting ‘‘12/31/2015’’. 

3 (b) EFFECTIVE DATE.—The amendment made by 

4 subsection (a) applies with respect to goods entered, or 

5 withdrawn from warehouse for consumption, on or after 

6 the 15th day after the date of the enactment of this Act. 

Æ 


tjames on DSK6SPTVN1PROD with BILLS
Section 1350

                             As Adopted Pursuant to

                  Section 906 of the Sarbanes-Oxley Act of 2002

I, Robert Sinnott, certify that:

      1.    I have reviewed this annual report on Form 10-KSB of Larrea
            BioSciences Corporation;

      2.    Based on my knowledge, this annual report does not contain any
            untrue statement of a material fact or omit to state a material fact
            necessary to make the statements made, in light of the circumstances
            under which such statements were made, not misleading with respect
            to the period covered by this annual report;

      3.    Based on my knowledge, the financial statements, and other financial
            information included in this annual report, fairly present in all
            material respects the financial condition, results of operations and
            cash flows of the registrant as of, and for, the periods presented
            in this annual report.

Date:  August 13, 2004                     /s/Robert Sinnott
                                           -------------------------------------
                                           Robert Sinnott
                                           Chief Financial Officer